Testing a new antibody drug in healthy volunteers
This trial tests a new antibody drug called CM583 in healthy people to see if it is safe and how the body handles it. It may help treat conditions related to certain proteins involved in pain and inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You must be a healthy volunteer and able to follow the study rules.
- You must not smoke more than 5 cigarettes a day on average in the last 3 months.
- You must not drink alcohol heavily in the last 3 months and must agree to avoid alcohol during the study.
- You must not have a history of drug abuse in the last year.
- You must not have donated or lost more than 400 mL of blood in the last 12 weeks.
- You must not have a known allergy to certain antibody drugs or have had severe allergic reactions to other drugs.
- You must not have had a severe injury or major surgery in the last 3 months, or plan to have surgery during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new investigational drug called CM383, which is a type of antibody (a protein that helps the immune system) possibly targeting brain plaque linked to Alzheimer's disease. It is an early-stage study in healthy volunteers to check safety and how the drug behaves in the body.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This trial tests a new drug called CAY001 in healthy volunteers to see how safe it is and how the body processes it. It may help researchers understand if the drug is safe enough to test in people with medical conditions later.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.